- CA$11.05m
- CA$29.19m
- CA$2.54m
Potential Customers From Germany, Poland, And Australia Have Scheduled EU-Gmp And Gmp Validation Audits Of Pharmacielo's Processes.
Brief: Pharmacielo Makes Initial Shipments To Two Brazilian Customers
Brief: Pharmacielo Ltd. Announces Upsize And Pricing Of Overnight Marketed Equity Offering
Brief: Pharmacielo Delivers First Commercial Shipment Of Thc-Free Broad-Spectrum Distillate
Brief: PharmaCielo Provides Update On GMP Compliance Process
Brief: PharmaCielo Enters Strategic Alliance To Provide Pre-Tested, Insured Product To Customers In U.S. Market
Brief: Pharmacielo Receives About Cdn$3.0 Mln In Non-Dilutive Funding From Banco Agrario
Brief: PharmaCielo Reports Q3 Loss Per Share $0.05
Brief: Pharmacielo Achieves Good Agricultural And Collection Practices (GACP) Designation
Brief: Pharmacielo Announces Upsizing Of Private Placement Offering
Canada Research Roundup: BRP, Pharmacielo, Vitalhub
Brief: Pharmacielo Announces Financial Results For Q2 And Provides Operational Update
Colombia Granted Co Authorization For Commercial Cultivation, Production, Export Of High-THC Medicinal Cannabis Extracts
Brief: Pharmacielo Posts Quarterly Loss Per Share Of $0.07
Brief: Pharmacielo Welcomes Dr. Claudia Jiménez To Board
Brief: PharmaCielo Announced Appointment Of Henning Von Koss To New Role Of President
Brief: Pharmacielo Says Pharmacielo Colombia Has Voluntarily Temporarily Ceased Cannabis Processing, At Processing Facility
Brief: Pharmacielo Issues Statement Regarding Misleading Short Seller Report
Brief: Pharmacielo Announces 30,000 KG Cannabis Extract Agreement For German Market